| Stem cell derived exosome therapy for clinical management of lung damage in critically-ill corona viral pneumonia patients | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Development of fluorescent human transmembrane serine protease 2 (TMPRSS2) activity sensor for rapid screening of inhibitors in vitro and in living cells to combat human COVID-19 and other respiratory infections. | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Aptamer-based rapid diagnostic kit for detection of coronavirus infection (CoVapt) | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Novel target identification and drug repositioning for COVID-19 based on interaction network, molecular design and machine learning | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Drug repurposing against key COVID-19 drug targets using advance machine learning-based algorithms | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Development of a portable optical cavity sterilisation unit | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Structural, biochemical and computational investigation on the therapeutic targets of SARS-CoV-2 and structure-based drug discovery from Indian herbs | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Understanding the role of SARS-CoV-2 virulence factor-Orf3a in modulating host cell responses: A way to identify host-directed therapy | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 for the development of inhibitors | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Development of a point-of-care fibre-optic biosensor (P-FAB) device for rapid detection of COVID-19 | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |